7
Views
81
CrossRef citations to date
0
Altmetric
Mammalian Genetic Models with Minimal or Complex Phenotypes

DNA Methyltransferase Deficiency Modifies Cancer Susceptibility in Mice Lacking DNA Mismatch Repair

, , , &
Pages 2906-2917 | Received 30 Oct 2001, Accepted 29 Jan 2002, Published online: 27 Mar 2023

REFERENCES

  • Ahuja, N., A. L. Mohan, Q. Li, J. M. Stolker, J. G. Herman, S. R. Hamilton, S. B. Baylin, and J. P. Issa. 1997. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57: 3370–3374.
  • Baker, S. M., C. E. Bronner, L. Zhang, A. W. Plug, M. Robatzek, G. Warren, E. A. Elliott, J. Yu, T. Ashley, N. Arnheim, et al. 1995. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82: 309–319.
  • Baker, S. M., A. W. Plug, T. A. Prolla, C. E. Bronner, A. C. Harris, X. Yao, D. M. Christie, C. Monell, N. Arnheim, A. Bradley, T. Ashley, and R. M. Liskay. 1996. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet. 13: 336–342.
  • Baylin, S. B., and J. G. Herman. 2000. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16: 168–174.
  • Bellacosa, A., L. Cicchillitti, F. Schepis, A. Riccio, A. T. Yeung, Y. Matsumoto, E. A. Golemis, M. Genuardi, and G. Neri. 1999. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc. Natl. Acad. Sci. USA 96: 3969–3974.
  • Berns, A., N. van der Lugt, M. Alkema, M. van Lohuizen, J. Domen, D. Acton, J. Allen, P. W. Laird, and J. Jonkers. 1994. Mouse model systems to study multistep tumorigenesis. Cold Spring Harbor Symp. Quant. Biol. 59: 435–447.
  • Chan, M. F., R. van Amerongen, T. Nijjar, E. Cuppen, P. A. Jones, and P. W. Laird. 2001. Reduced rates of gene loss, gene silencing, and gene mutation in dnmt1-deficient embryonic stem cells. Mol. Cell. Biol. 21: 7587–7600.
  • Chapman, V., L. Forrester, J. Sanford, N. Hastie, and J. Rossant. 1984. Cell lineage-specific undermethylation of mouse repetitive DNA. Nature 307: 284–286.
  • Chen, D., C. L. Luongo, M. L. Nibert, and J. T. Patton. 1999. Rotavirus open cores catalyze 5′-capping and methylation of exogenous RNA: evidence that VP3 is a methyltransferase. Virology 265: 120–130.
  • Chen, R. Z., U. Pettersson, C. Beard, L. Jackson-Grusby, and R. Jaenisch. 1998. DNA hypomethylation leads to elevated mutation rates. Nature 395: 89–93.
  • Chuang, L. S., H. I. Ian, T. W. Koh, H. H. Ng, G. Xu, and B. F. Li. 1997. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 277: 1996–2000.
  • Cormier, R. T., and W. F. Dove. 2000. Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele. Cancer Res. 60: 3965–3970.
  • Cui, H., I. L. Horon, R. Ohlsson, S. R. Hamilton, and A. P. Feinberg. 1998. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med. 4: 1276–1280.
  • de Vries, S. S., E. B. Baart, M. Dekker, A. Siezen, D. G. de Rooij, P. de Boer, and H. te Riele. 1999. Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis. Genes Dev. 13: 523–531.
  • de Wind, N., M. Dekker, A. Berns, M. Radman, and H. te Riele. 1995. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82: 321–330.
  • Eads, C. A., K. D. Danenberg, K. Kawakami, L. B. Saltz, C. Blake, D. Shibata, P. V. Danenberg, and P. W. Laird. 2000. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28: E32.
  • Eads, C. A., K. D. Danenberg, K. Kawakami, L. B. Saltz, P. V. Danenberg, and P. W. Laird. 1999. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 59: 2302–2306.
  • Eads, C. A., R. V. Lord, S. K. Kurumboor, K. Wickramasinghe, M. L. Skinner, T. I. Long, J. H. Peters, T. R. DeMeester, K. D. Danenberg, P. V. Danenberg, P. W. Laird, and K. A. Skinner. 2000. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 60: 5021–5026.
  • Eads, C. A., R. V. Lord, K. Wickramasinghe, T. I. Long, S. K. Kurumboor, L. Bernstein, J. H. Peters, S. R. DeMeester, T. R. DeMeester, K. A. Skinner, and P. W. Laird. 2001. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61: 3410–3418.
  • Edelmann, W., P. E. Cohen, M. Kane, K. Lau, B. Morrow, S. Bennett, A. Umar, T. Kunkel, G. Cattoretti, R. Chaganti, J. W. Pollard, R. D. Kolodner, and R. Kucherlapati. 1996. Meiotic pachytene arrest in MLH1-deficient mice. Cell 85: 1125–1134.
  • Edelmann, W., P. E. Cohen, B. Kneitz, N. Winand, M. Lia, J. Heyer, R. Kolodner, J. W. Pollard, and R. Kucherlapati. 1999. Mammalian MutS homologue 5 is required for chromosome pairing in meiosis. Nat. Genet. 21: 123–127.
  • Edelmann, W., K. Yang, M. Kuraguchi, J. Heyer, M. Lia, B. Kneitz, K. Fan, A. M. Brown, M. Lipkin, and R. Kucherlapati. 1999. Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Res. 59: 1301–1307.
  • Edelmann, W., K. Yang, A. Umar, J. Heyer, K. Lau, K. Fan, W. Liedtke, P. E. Cohen, M. F. Kane, J. R. Lipford, N. Yu, G. F. Crouse, J. W. Pollard, T. Kunkel, M. Lipkin, R. Kolodner, and R. Kucherlapati. 1997. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell 91: 467–477.
  • El-Deiry, W. S., B. D. Nelkin, P. Celano, R. W. Yen, J. P. Falco, S. R. Hamilton, and S. B. Baylin. 1991. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. USA 88: 3470–3474.
  • Feinberg, A. P., C. W. Gehrke, K. C. Kuo, and M. Ehrlich. 1988. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48: 1159–1161.
  • Fuks, F., W. A. Burgers, A. Brehm, L. Hughes-Davies, and T. Kouzarides. 2000. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24: 88–91.
  • Goelz, S. E., B. Vogelstein, S. R. Hamilton, and A. P. Feinberg. 1985. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187–190.
  • Hansen, R. S., C. Wijmenga, P. Luo, A. M. Stanek, T. K. Canfield, C. M. Weemaes, and S. M. Gartler. 1999. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 96: 14412–14417.
  • Hare, J. T., and J. H. Taylor. 1985. One role for DNA methylation in vertebrate cells is strand discrimination in mismatch repair. Proc. Natl. Acad. Sci. USA 82: 7350–7354.
  • Hata, K., and Y. Sakaki. 1997. Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene 189: 227–234.
  • Hellmann-Blumberg, U., M. F. Hintz, J. M. Gatewood, and C. W. Schmid. 1993. Developmental differences in methylation of human Alu repeats. Mol. Cell. Biol. 13: 4523–4530.
  • Herman, J. G., and S. B. Baylin. 2000. Promoter-region hypermethylation and gene silencing in human cancer. Curr. Top. Microbiol. Immunol. 249: 35–54.
  • Herman, J. G., A. Umar, K. Polyak, J. R. Graff, N. Ahuja, J. P. Issa, S. Markowitz, J. K. Willson, S. R. Hamilton, K. W. Kinzler, M. F. Kane, R. D. Kolodner, B. Vogelstein, T. A. Kunkel, and S. B. Baylin. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95: 6870–6875.
  • Howell, C. Y., T. H. Bestor, F. Ding, K. E. Latham, C. Mertineit, J. M. Trasler, and J. R. Chaillet. 2001. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 104: 829–838.
  • Issa, J. P., P. M. Vertino, J. Wu, S. Sazawal, P. Celano, B. D. Nelkin, S. R. Hamilton, and S. B. Baylin. 1993. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl. Cancer Inst. 85: 1235–1240.
  • Jackson-Grusby, L., C. Beard, R. Possemato, M. Tudor, D. Fambrough, G. Csankovszki, J. Dausman, P. Lee, C. Wilson, E. Lander, and R. Jaenisch. 2001. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet. 27: 31–39.
  • Jackson-Grusby, L., P. W. Laird, S. N. Magge, B. J. Moeller, and R. Jaenisch. 1997. Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc. Natl. Acad. Sci. USA 94: 4681–4685.
  • Jones, P. A., and P. W. Laird. 1999. Cancer epigenetics comes of age. Nat. Genet. 21: 163–167.
  • Jones, P. L., G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass, N. Landsberger, J. Strouboulis, and A. P. Wolffe. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19: 187–191.
  • Kautiainen, T. L., and P. A. Jones. 1986. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J. Biol. Chem. 261: 1594–1598.
  • Knox, J. D., F. D. Araujo, P. Bigey, A. D. Slack, G. B. Price, M. Zannis-Hadjopoulos, and M. Szyf. 2000. Inhibition of DNA methyltransferase inhibits DNA replication. J. Biol. Chem. 275: 17986–17990.
  • Kochanek, S., D. Renz, and W. Doerfler. 1995. Transcriptional silencing of human Alu sequences and inhibition of protein binding in the box B regulatory elements by 5′-CG-3′ methylation. FEBS Lett. 360: 115–120.
  • Labow, M. A. 1995. Use of lac activator proteins for regulated expression of oncogenes. Methods Enzymol. 254: 375–387.
  • Labow, M. A., S. B. Baim, T. Shenk, and A. J. Levine. 1990. Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells. Mol. Cell. Biol. 10: 3343–3356.
  • Laird, P. W. 2000. Mouse models in DNA-methylation research. Curr. Top. Microbiol. Immunol. 249: 119–134.
  • Laird, P. W., L. Jackson-Grusby, A. Fazeli, S. L. Dickinson, W. E. Jung, E. Li, R. A. Weinberg, and R. Jaenisch. 1995. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197–205.
  • Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19: 4293.
  • Lee, P. J., L. L. Washer, D. J. Law, C. R. Boland, I. L. Horon, and A. P. Feinberg. 1996. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc. Natl. Acad. Sci. USA 93: 10366–10370.
  • Lei, H., S. P. Oh, M. Okano, R. Juttermann, K. A. Goss, R. Jaenisch, and E. Li. 1996. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122: 3195–3205.
  • Lengauer, C., K. W. Kinzler, and B. Vogelstein. 1997. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 94: 2545–2550.
  • Leonhardt, H., A. W. Page, H. U. Weier, and T. H. Bestor. 1992. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865–873.
  • Li, E., T. H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915–926.
  • Liu, W. M., and C. W. Schmid. 1993. Proposed roles for DNA methylation in Alu transcriptional repression and mutational inactivation. Nucleic Acids Res. 21: 1351–1359.
  • Lu, A. L., S. Clark, and P. Modrich. 1983. Methyl-directed repair of DNA base-pair mismatches in vitro. Proc. Natl. Acad. Sci. USA 80: 4639–4643.
  • MacLeod, A. R., and M. Szyf. 1995. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Biol. Chem. 270: 8037–8043.
  • Nakagawa, H., R. B. Chadwick, P. Peltomaki, C. Plass, Y. Nakamura, and A. de La Chapelle. 2000. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl. Acad. Sci. USA 19: 19.
  • Nan, X., F. J. Campoy, and A. Bird. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471–481.
  • Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386–389.
  • Ng, H. H., and A. Bird. 1999. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 9: 158–163.
  • Okano, M., D. W. Bell, D. A. Haber, and E. Li. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247–257.
  • Okano, M., S. Xie, and E. Li. 1998. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19: 219–220.
  • Olek, A., J. Oswald, and J. Walter. 1996. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res. 24: 5064–5066.
  • Pao, M. M., G. Liang, Y. C. Tsai, Z. Xiong, P. W. Laird, and P. A. Jones. 2000. DNA methylator and mismatch repair phenotypes are not mutually exclusive in colorectal cancer cell lines. Oncogene 19: 943–952.
  • Prolla, T. A., S. M. Baker, A. C. Harris, J. L. Tsao, X. Yao, C. E. Bronner, B. Zheng, M. Gordon, J. Reneker, N. Arnheim, D. Shibata, A. Bradley, and R. M. Liskay. 1998. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat. Genet. 18: 276–279.
  • Ramchandani, S., A. R. MacLeod, M. Pinard, E. von Hofe, and M. Szyf. 1997. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 94: 684–689.
  • Reitmair, A. H., R. Schmits, A. Ewel, B. Bapat, M. Redston, A. Mitri, P. Waterhouse, H. W. Mittrucker, A. Wakeham, B. Liu, et al. 1995. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet. 11: 64–70.
  • Robertson, K. D., S. Ait-Si-Ali, T. Yokochi, P. A. Wade, P. L. Jones, and A. P. Wolffe. 2000. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25: 338–342.
  • Robertson, K. D., and P. A. Jones. 1997. Dynamic interrelationships between DNA replication, methylation, and repair. Am. J. Hum. Genet. 61: 1220–1224.
  • Robertson, K. D., K. Keyomarsi, F. A. Gonzales, M. Velicescu, and P. A. Jones. 2000. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res. 28: 2108–2113.
  • Robertson, K. D., E. Uzvolgyi, G. Liang, C. Talmadge, J. Sumegi, F. A. Gonzales, and P. A. Jones. 1999. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27: 2291–2298.
  • Robertson, K. D., and A. P. Wolffe. 2000. DNA methylation in health and disease. Nat. Rev. Genet. 1: 11.
  • Rountree, M. R., K. E. Bachman, and S. B. Baylin. 2000. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25: 269–277.
  • Sollbach, A. E., and G. E. Wu. 1995. Inversions produced during V(D)J rearrangement at IgH, the immunoglobulin heavy-chain locus. Mol. Cell. Biol. 15: 671–681.
  • Strand, M., T. A. Prolla, R. M. Liskay, and T. D. Petes. 1993. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365: 274–276.
  • Toyota, M., N. Ahuja, M. Ohe-Toyota, J. G. Herman, S. B. Baylin, and J. P. Issa. 1999. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96: 8681–8686.
  • Tucker, K. L., C. Beard, J. Dausmann, L. Jackson-Grusby, P. W. Laird, H. Lei, E. Li, and R. Jaenisch. 1996. Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev. 10: 1008–1020.
  • Umar, A., J. C. Boyer, and T. A. Kunkel. 1994. DNA loop repair by human cell extracts. Science 266: 814–816.
  • Umar, A., A. B. Buermeyer, J. A. Simon, D. C. Thomas, A. B. Clark, R. M. Liskay, and T. A. Kunkel. 1996. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87: 65–73.
  • van Lohuizen, M., S. Verbeek, P. Krimpenfort, J. Domen, C. Saris, T. Radaszkiewicz, and A. Berns. 1989. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56: 673–682.
  • van Lohuizen, M., S. Verbeek, B. Scheijen, E. Wientjens, H. van der Gulden, and A. Berns. 1991. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65: 737–752.
  • Veigl, M. L., L. Kasturi, J. Olechnowicz, A. H. Ma, J. D. Lutterbaugh, S. Periyasamy, G. M. Li, J. Drummond, P. L. Modrich, W. D. Sedwick, and S. D. Markowitz. 1998. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl. Acad. Sci. USA 95: 8698–8702.
  • Walsh, C. P., J. R. Chaillet, and T. H. Bestor. 1998. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat. Genet. 20: 116–117.
  • Warbrick, E. 1998. PCNA binding through a conserved motif. Bioessays 20: 195–199.
  • Warbrick, E. 2000. The puzzle of PCNA's many partners. Bioessays 22: 997–1006.
  • Whitehurst, C. E., S. Chattopadhyay, and J. Chen. 1999. Control of V(D)J recombinational accessibility of the D beta 1 gene segment at the TCR beta locus by a germline promoter. Immunity 10: 313–322.
  • Xiong, Z., A. H. Wu, C. M. Bender, J. L. Tsao, C. Blake, D. Shibata, P. A. Jones, M. C. Yu, R. K. Ross, and P. W. Laird. 2001. Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomas. Cancer Epidemiol. Biomarkers Prev. 10: 799–803.
  • Xu, G. L., T. H. Bestor, D. Bourc'his, C. L. Hsieh, N. Tommerup, M. Bugge, M. Hulten, X. Qu, J. J. Russo, and E. Viegas-Pequignot. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402: 187–191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.